Suchergebnisse - "Li, Xingya"

PubPharm (133)

1

KN046, a bispecific antibody against PD-L1 and CTLA-4, plus chemotherapy as first-line treatment for metastatic NSCLC : A multicenter phase 2 trial

enthalten in: Cell reports. Medicine | 2024

von Zhao, Y. | Chen, G. | Li, X. | +9

2

Tislelizumab Plus Platinum and Etoposide Versus Placebo Plus Platinum and Etoposide as First-Line Treatment for Extensive-Stage SCLC (RATIONALE-312) : A Multicenter, Double-Blind, Placebo-Controlled, Randomized, Phase 3 Clinical Trial

enthalten in: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer | 2024

von Cheng, Y. | Fan, Y. | Zhao, Y. | +16

3

Advancing Ion Selective Membranes with Micropore Ion Channels in the Interaction Confinement Regime

enthalten in: ACS nano | 2024

von Zuo, P. | Ran, J. | Ye, C. | +3

4

A phase Ib/II study of cadonilimab (PD-1/CTLA-4 bispecific antibody) plus anlotinib as first-line treatment in patients with advanced non-small cell lung cancer

enthalten in: British journal of cancer | 2024

von Chen, B. | Yao, W. | Li, X. | +21

5

Efficacy of immune checkpoint inhibitors in advanced large cell neuroendocrine carcinoma of the lung : A single‑institution experience

enthalten in: Oncology letters | 2024

von Yan, N. | Guo, S. | Zhang, Z. | +2

6

A pivotal bridging study of lurbinectedin as second-line therapy in Chinese patients with small cell lung cancer

enthalten in: Scientific reports | 2024

von Cheng, Y. | Wu, C. | Wu, L. | +12

7

Response to immune checkpoint inhibitor combination therapy in metastatic RET-mutated lung cancer from real-world retrospective data

enthalten in: BMC cancer | 2024

von Yan, N. | Zhang, H. | Shen, S. | +2

8

Response to immune checkpoint inhibitor combination therapy in metastatic RET-mutated lung cancer from real-world retrospective data

enthalten in: BMC cancer | 2024

von Yan, N. | Zhang, H. | Shen, S. | +2

9

Ficonalkib (SY-3505) in Advanced ALK-Positive NSCLC : A Multicenter, Open-Label, Single-Arm, Phase 1/2 Study

enthalten in: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer | 2024

von Shi, Y. | Hu, X. | Li, X. | +15

10

Efficacy of chemo-immunotherapy in metastatic BRAF-mutated lung cancer : a single-center retrospective data

enthalten in: Frontiers in oncology | 2024

von Yan, N. | Zhang, H. | Guo, S. | +4

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[14]